1h Free Analyst Time
The pharmaceutical market in denmark is forecasted to grow by USD 843.4 million during 2024-2029, accelerating at a CAGR of 3.5% during the forecast period. The report on the pharmaceutical market in denmark provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high investment in pharmaceutical industry, growing prevalence of chronic conditions in denmark, and increasing geriatric population in denmark.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The pharmaceutical market in denmark is segmented as below:
By Class Type
- Musculoskeletal system
- Nervous system
- Respiratory system
- Others
By Distribution Channel
- Offline
- Online
By Type
- Prescription drugs
- OTC drugs
By Drug Class
- Branded drugs
- Generic drugs
By Sector
- Primary sector
- Hospital sector
By Geographical Landscape
- Europe
The report on the pharmaceutical market in denmark covers the following areas:
- Pharmaceutical Market in Denmark sizing
- Pharmaceutical Market in Denmark forecast
- Pharmaceutical Market in Denmark industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Class Type
9 Market Segmentation by Distribution Channel
10 Market Segmentation by Type
11 Market Segmentation by Drug Class
12 Market Segmentation by Sector
13 Customer Landscape
14 Drivers, Challenges, and Opportunity/Restraints
15 Competitive Landscape
16 Competitive Analysis
17 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the pharmaceutical market in denmark: Abblo Pharma, ALK Abello AS, AstraZeneca Plc, Biogen Inc., DanCann Pharma AS, F. Hoffmann La Roche Ltd., Ferring BV, GlaxoSmithKline Plc, H Lundbeck AS, LEO Pharma AS, Novo Nordisk AS, ORIFARM GROUP AS, Orion Corp., Pfizer Inc., Sandoz Group AG, Sanofi SA, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., UCB SA, and Vifor Pharma Management Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is high demand for personalized medicines."
According to the report, one of the major drivers for this market is the high investment in pharmaceutical industry.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abblo Pharma
- ALK Abello AS
- AstraZeneca Plc
- Biogen Inc.
- DanCann Pharma AS
- F. Hoffmann La Roche Ltd.
- Ferring BV
- GlaxoSmithKline Plc
- H Lundbeck AS
- LEO Pharma AS
- Novo Nordisk AS
- ORIFARM GROUP AS
- Orion Corp.
- Pfizer Inc.
- Sandoz Group AG
- Sanofi SA
- Sun Pharmaceutical Industries Ltd.
- Takeda Pharmaceutical Co. Ltd.
- UCB SA
- Vifor Pharma Management Ltd.
